1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 United States Sepsis Diagnostics Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 United States Sepsis Diagnostics Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 United States Sepsis Diagnostics Market - Breakup by Diagnosis
6.1 Automated Diagnostics
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Forecast (2024-2032)
6.2 Conventional Diagnostics
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Forecast (2024-2032)
7 United States Sepsis Diagnostics Market - Breakup by Product
7.1 Instruments
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Forecast (2024-2032)
7.2 Assay Kits and Reagents
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Forecast (2024-2032)
7.3 Blood Culture Media
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2018-2023)
7.3.3 Market Forecast (2024-2032)
7.4 Software
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2018-2023)
7.4.3 Market Forecast (2024-2032)
8 United States Sepsis Diagnostics Market - Breakup by Mode of Testing
8.1 Laboratory Tests
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Forecast (2024-2032)
8.2 Point-of-Care Tests
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Forecast (2024-2032)
9 United States Sepsis Diagnostics Market - Breakup by Technology
9.1 Molecular Diagnostics
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2018-2023)
9.1.3 Market Forecast (2024-2032)
9.2 Immunoassays
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2018-2023)
9.2.3 Market Forecast (2024-2032)
9.3 Biomarkers
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2018-2023)
9.3.3 Market Forecast (2024-2032)
9.4 Flow Cytometry
9.4.1 Overview
9.4.2 Historical and Current Market Trends (2018-2023)
9.4.3 Market Forecast (2024-2032)
9.5 Microfluidics
9.5.1 Overview
9.5.2 Historical and Current Market Trends (2018-2023)
9.5.3 Market Forecast (2024-2032)
9.6 Blood Culture
9.6.1 Overview
9.6.2 Historical and Current Market Trends (2018-2023)
9.6.3 Market Forecast (2024-2032)
10 United States Sepsis Diagnostics Market - Breakup by Pathogen
10.1 Bacterial Sepsis
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2018-2023)
10.1.3 Market Segmentation
10.1.3.1 Gram-Positive Bacterial Sepsis
10.1.3.2 Gram-Negative Bacterial Sepsis
10.1.4 Market Forecast (2024-2032)
10.2 Viral Sepsis
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2018-2023)
10.2.3 Market Forecast (2024-2032)
10.3 Fungal Sepsis
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2018-2023)
10.3.3 Market Forecast (2024-2032)
10.4 Others
10.4.1 Historical and Current Market Trends (2018-2023)
10.4.2 Market Forecast (2024-2032)
11 United States Sepsis Diagnostics Market - Breakup by End User
11.1 Diagnostic Clinics
11.1.1 Overview
11.1.2 Historical and Current Market Trends (2018-2023)
11.1.3 Market Forecast (2024-2032)
11.2 Hospitals
11.2.1 Overview
11.2.2 Historical and Current Market Trends (2018-2023)
11.2.3 Market Forecast (2024-2032)
11.3 Research Laboratories
11.3.1 Overview
11.3.2 Historical and Current Market Trends (2018-2023)
11.3.3 Market Forecast (2024-2032)
12 United States Sepsis Diagnostics Market – Breakup by Region
12.1 Northeast
12.1.1 Overview
12.1.2 Historical and Current Market Trends (2018-2023)
12.1.3 Market Breakup by Diagnosis
12.1.4 Market Breakup by Product
12.1.5 Market Breakup by Mode of Testing
12.1.6 Market Breakup by Technology
12.1.7 Market Breakup by Pathogen
12.1.8 Market Breakup by End User
12.1.9 Key Players
12.1.10 Market Forecast (2024-2032)
12.2 Midwest
12.2.1 Overview
12.2.2 Historical and Current Market Trends (2018-2023)
12.2.3 Market Breakup by Diagnosis
12.2.4 Market Breakup by Product
12.2.5 Market Breakup by Mode of Testing
12.2.6 Market Breakup by Technology
12.2.7 Market Breakup by Pathogen
12.2.8 Market Breakup by End User
12.2.9 Key Players
12.2.10 Market Forecast (2024-2032)
12.3 South
12.3.1 Overview
12.3.2 Historical and Current Market Trends (2018-2023)
12.3.3 Market Breakup by Diagnosis
12.3.4 Market Breakup by Product
12.3.5 Market Breakup by Mode of Testing
12.3.6 Market Breakup by Technology
12.3.7 Market Breakup by Pathogen
12.3.8 Market Breakup by End User
12.3.9 Key Players
12.3.10 Market Forecast (2024-2032)
12.4 West
12.4.1 Overview
12.4.2 Historical and Current Market Trends (2018-2023)
12.4.3 Market Breakup by Diagnosis
12.4.4 Market Breakup by Product
12.4.5 Market Breakup by Mode of Testing
12.4.6 Market Breakup by Technology
12.4.7 Market Breakup by Pathogen
12.4.8 Market Breakup by End User
12.4.9 Key Players
12.4.10 Market Forecast (2024-2032)
13 United States Sepsis Diagnostics Market – Competitive Landscape
13.1 Overview
13.2 Market Structure
13.3 Market Player Positioning
13.4 Top Winning Strategies
13.5 Competitive Dashboard
13.6 Company Evaluation Quadrant
14 Profiles of Key Players
14.1 Company A
14.1.1 Business Overview
14.1.2 Product Portfolio
14.1.3 Business Strategies
14.1.4 SWOT Analysis
14.1.5 Major News and Events
14.2 Company B
14.2.1 Business Overview
14.2.2 Product Portfolio
14.2.3 Business Strategies
14.2.4 SWOT Analysis
14.2.5 Major News and Events
14.3 Company C
14.3.1 Business Overview
14.3.2 Product Portfolio
14.3.3 Business Strategies
14.3.4 SWOT Analysis
14.3.5 Major News and Events
14.4 Company D
14.4.1 Business Overview
14.4.2 Product Portfolio
14.4.3 Business Strategies
14.4.4 SWOT Analysis
14.4.5 Major News and Events
14.5 Company E
14.5.1 Business Overview
14.5.2 Product Portfolio
14.5.3 Business Strategies
14.5.4 SWOT Analysis
14.5.5 Major News and Events
Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.
15 United States Sepsis Diagnostics Market - Industry Analysis
15.1 Drivers, Restraints, and Opportunities
15.1.1 Overview
15.1.2 Drivers
15.1.3 Restraints
15.1.4 Opportunities
15.2 Porters Five Forces Analysis
15.2.1 Overview
15.2.2 Bargaining Power of Buyers
15.2.3 Bargaining Power of Suppliers
15.2.4 Degree of Competition
15.2.5 Threat of New Entrants
15.2.6 Threat of Substitutes
15.3 Value Chain Analysis
16 Appendix